demonstrated suggested inconclusive safety concern ongoing study display ongoing demontrated benefit only
COVID-19 mild to moderate
COVID 19 hospitalizedCOVID-19 mild to moderate
sofosbuvir and ledipasvir Elgohary Nourian A

0 studies excluded by filtering options 0